147 related articles for article (PubMed ID: 27209699)
21. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
[TBL] [Abstract][Full Text] [Related]
22. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
Persson AA; Gunnarsson P; Lindström E; Grenegård M
Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
[TBL] [Abstract][Full Text] [Related]
23. Dinuclear copper complexes of organic claw: potent inhibition of protein tyrosine phosphatases.
Ma L; Lu L; Zhu M; Wang Q; Gao F; Yuan C; Wu Y; Xing S; Fu X; Mei Y; Gao X
J Inorg Biochem; 2011 Sep; 105(9):1138-47. PubMed ID: 21708098
[TBL] [Abstract][Full Text] [Related]
24. Structural basis for inhibition of protein tyrosine phosphatases by Keggin compounds phosphomolybdate and phosphotungstate.
Heo YS; Ryu JM; Park SM; Park JH; Lee HC; Hwang KY; Kim J
Exp Mol Med; 2002 Jul; 34(3):211-23. PubMed ID: 12216113
[TBL] [Abstract][Full Text] [Related]
25. Enhancement or induction of neurite formation by a protein tyrosine phosphatase inhibitor, 3,4-dephostatin, in growth factor-treated PC12h cells.
Fujiwara S; Watanabe T; Nagatsu T; Gohda J; Imoto M; Umezawa K
Biochem Biophys Res Commun; 1997 Sep; 238(1):213-7. PubMed ID: 9299481
[TBL] [Abstract][Full Text] [Related]
26. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
[TBL] [Abstract][Full Text] [Related]
27. Dephostatin, a novel protein tyrosine phosphatase inhibitor produced by Streptomyces. I. Taxonomy, isolation, and characterization.
Imoto M; Kakeya H; Sawa T; Hayashi C; Hamada M; Takeuchi T; Umezawa K
J Antibiot (Tokyo); 1993 Sep; 46(9):1342-6. PubMed ID: 8226312
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and protein tyrosine phosphatase inhibitory activity of dephostatin analogs.
Watanabe T; Takeuchi T; Otsuka M; Tanaka S; Umezawa K
J Antibiot (Tokyo); 1995 Dec; 48(12):1460-6. PubMed ID: 8557604
[TBL] [Abstract][Full Text] [Related]
29. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation.
Hutter D; Chen P; Barnes J; Liu Y
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068
[TBL] [Abstract][Full Text] [Related]
30. Protein phosphatase Dusp26 associates with KIF3 motor and promotes N-cadherin-mediated cell-cell adhesion.
Tanuma N; Nomura M; Ikeda M; Kasugai I; Tsubaki Y; Takagaki K; Kawamura T; Yamashita Y; Sato I; Sato M; Katakura R; Kikuchi K; Shima H
Oncogene; 2009 Feb; 28(5):752-61. PubMed ID: 19043453
[TBL] [Abstract][Full Text] [Related]
31. Effects of SOV-induced phosphatase inhibition and expression of protein tyrosine phosphatases in rat corneal endothelial cells.
Chen WL; Harris DL; Joyce NC
Exp Eye Res; 2005 Nov; 81(5):570-80. PubMed ID: 15950220
[TBL] [Abstract][Full Text] [Related]
32. MKP-8, a novel MAPK phosphatase that inhibits p38 kinase.
Vasudevan SA; Skoko J; Wang K; Burlingame SM; Patel PN; Lazo JS; Nuchtern JG; Yang J
Biochem Biophys Res Commun; 2005 May; 330(2):511-8. PubMed ID: 15796912
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel DUSP16 phosphatase inhibitors through virtual screening with homology modeled protein structure.
Park H; Park SY; Nam SW; Ryu SE
J Biomol Screen; 2014 Dec; 19(10):1383-90. PubMed ID: 25245988
[TBL] [Abstract][Full Text] [Related]
34. Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.
Lazo JS; Nunes R; Skoko JJ; Queiroz de Oliveira PE; Vogt A; Wipf P
Bioorg Med Chem; 2006 Aug; 14(16):5643-50. PubMed ID: 16698271
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2.
Cadalbert LC; Sloss CM; Cunningham MR; Al-Mutairi M; McIntire A; Shipley J; Plevin R
Cell Signal; 2010 Mar; 22(3):357-65. PubMed ID: 19843478
[TBL] [Abstract][Full Text] [Related]
36. Expression, purification, and enzymatic characterization of the dual specificity mitogen-activated protein kinase phosphatase, MKP-4.
Hong SB; Lubben TH; Dolliver CM; Petrolonis AJ; Roy RA; Li Z; Parsons TF; Li P; Xu H; Reilly RM; Trevillyan JM; Nichols AJ; Tummino PJ; Gant TG
Bioorg Chem; 2005 Feb; 33(1):34-44. PubMed ID: 15668181
[TBL] [Abstract][Full Text] [Related]
37. Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.
Matsubara H; Shibasaki Y; Okigaki M; Mori Y; Masaki H; Kosaki A; Tsutsumi Y; Uchiyama Y; Fujiyama S; Nose A; Iba O; Tateishi E; Hasegawa T; Horiuchi M; Nahmias C; Iwasaka T
Biochem Biophys Res Commun; 2001 Apr; 282(5):1085-91. PubMed ID: 11302725
[TBL] [Abstract][Full Text] [Related]
38. Mitogen-Activated Protein Kinase Phosphatases: No Longer Undruggable?
Shillingford SR; Bennett AM
Annu Rev Pharmacol Toxicol; 2023 Jan; 63():617-636. PubMed ID: 36662585
[TBL] [Abstract][Full Text] [Related]
39. A one-step method to identify MAP kinase residues involved in inactivation by tyrosine- and dual-specificity protein phosphatases.
Tárrega C; Pulido R
Anal Biochem; 2009 Nov; 394(1):81-6. PubMed ID: 19583964
[TBL] [Abstract][Full Text] [Related]
40. Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death.
Eroglu B; Jin X; Deane S; Öztürk B; Ross OA; Moskophidis D; Mivechi NF
Cell Mol Life Sci; 2022 Mar; 79(4):198. PubMed ID: 35313355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
